AGXT2 antibody (AA 196-328)
Quick Overview for AGXT2 antibody (AA 196-328) (ABIN7143624)
Target
See all AGXT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 196-328
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Alanine--glyoxylate aminotransferase 2, mitochondrial protein (196-328AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:200-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- AGXT2 (Alanine Glyoxylate Aminotransferase 2 (AGXT2))
-
Alternative Name
- AGXT2
-
Background
-
Background: Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure.
Aliases: AGXT2 antibody, AGT2Alanine--glyoxylate aminotransferase 2 antibody, mitochondrial antibody, AGT 2 antibody, EC 2.6.1.44, antibody, R)-3-amino-2-methylpropionate--pyruvate transaminase antibody, EC 2.6.1.40 antibody, Beta-ALAAT II antibody, Beta-alanine-pyruvate aminotransferase antibody, D-AIBAT antibody
-
UniProt
- Q9BYV1
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-